Neuroprotective effects of a novel water-soluble poly(ADP-ribose) polymerase-1 inhibitor, MP-124, in in vitro and in vivo models of cerebral ischemia-Reference-Cited by-同舟云学术

Neuroprotective effects of a novel water-soluble poly(ADP-ribose) polymerase-1 inhibitor, MP-124, in in vitro and in vivo models of cerebral ischemia

Published:2011-05 Issue: Volume:1389 Page:169-176
ISSN:0006-8993
Container-title:Brain Research
language:en
Short-container-title:Brain Research

Author:

Egi Yasuhiro,Matsuura Shigeru,Maruyama Tomoyuki,Fujio Masakazu,Yuki Satoshi,Akira Toshiaki

Publisher

Elsevier BV

Subject

Developmental Biology,Clinical Neurology,Molecular Biology,General Neuroscience

Reference35 articles.

1. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase in in vitro and in vivo models of stroke;Abdelkarim;Int. J. Mol. Med.,2001

2. Focal brain ischemia in the rat: methods for reproducible neocortical infarction using tandem occlusion of the distal middle cerebral and ipsilateral common carotid arteries;Brint;J. Cereb. Blood Flow Metab.,1988

3. Physiology and pathophysiology of poly(ADP-ribosyl)ation;Burkle;BioEssay.,2001

4. Reactive oxygen radicals in signaling and damage in the ischemic brain;Chan;J. Cereb. Blood Flow Metab.,2001

5. PARP-1: killer or conspirator? Suicide hypothesis revisited;Chiarugi;Trends Pharmacol. Sci.,2002

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Poly (ADP-Ribose) polymerase 1 and parthanatos in neurological diseases: From pathogenesis to therapeutic opportunities;Neurobiology of Disease;2023-10

2. Ability of metformin to deplete NAD+ contributes to cancer cell susceptibility to metformin cytotoxicity and is dependent on NAMPT expression;Frontiers in Oncology;2023-07-31

3. Radiation-induced neuroinflammation: a potential protective role for poly(ADP-ribose) polymerase inhibitors?;Neuro-Oncology Advances;2022-01-01

4. Targeting Parthanatos in Ischemic Stroke;Frontiers in Neurology;2021-05-05

5. New insights of poly(ADP-ribosylation) in neurodegenerative diseases: A focus on protein phase separation and pathologic aggregation;Biochemical Pharmacology;2019-09